Ahmedabad based Cadila pharmaceuticals Limited is one of the largest privately held pharmaceutical companies in India. The company has been manufacturing pharmaceutical products and distributing & selling these products in more then hundred other countries around the world.
About Cadila Pharmaceuticals
Cadila pharmaceutical is a multinational research based pharmaceutical company in India. Shri Indravadan Modi (an Indian Pharmaceuticals industry tycoon) founded the company.
It has more than 6-decades of experience. Cadila’s integrated operations covers total gamut from manufacturing products ranging from API’s-Intermediates, OTC-food supplements, biotechnology products, finished formulations & pharmaceutical machinery.
Most stringent International bodies like WHO-GMP, UK-MHRA, USFDA-API, TGA-Australia, and AIFA-Italy, approve Cadila Pharmaceuticals manufacturing facilities.
International operations of the company have spread across 58 countries including America, Japan, CIS, Africa and Asia.
Company History:
Cadila Laboratories:
In the year 1951, Indravadan Ambalal Modi, popularly known as Indravadan Modi quit his job as a chemist and started Cadila Laboratories with his childhood friend Ramanlal Patel.
They started the company in a rented bungalow with a capital of ₹ 25,000. They achieved a turnover of around ₹ 1.25 lakh in its first year.
Demerger of Cadila Laboratories
Both Modi and Patel family decided to split the business in 1995. Two entities were formed 1: Cadila Pharmaceuticals Ltd. & 2: Cadila Healthcare.
1: Cadila Pharmaceuticals was owned and controlled by Shri Indravadan A Modi & his son Dr. Rajiv Modi.
2: Cadila Healthcare was owned and controlled by Shri Ramanbhai Patel & his son Pankaj Patel family.
DR.Rajiv Modi and Indravadan. A. Modi worked hard to run Cadila pharmaceuticals. Now cadila is considered as one of the largest privetly-held pharmaceutical companies in India with the revenue of around ₹ 1200 crore.
Operations:
The company has its formulation-manufacturing unit at Dholka, Gujarat, Samba, and Jammu India & at Addis Ababa-Ethiopia.
They have 2-API manufacturing facilities are located in Ankleshwar, Gujarat. Manufacturing unit at Dholka and API unit at Ankleshwar are USFDA-certified.
Cadila’s state-of-the-art manufacturing unit at Ethopia is the WHO-cGMP compliant facility.
Research Centre:
In Dholka India, Cadila has established a dedicated R&D facility. It is spread over 1,05,000 sq. ft. area. 300-scientists operate it.
They have filed 5-IND dossiers filed with USFDA for pulmonary tuberculosis, prostate cancer, bladder cancer, lung cancer and melanoma. Cadila has submitted 10-ANDAs. They have connection with various industries for research.
Some of them are Department of Biotechnology, UDSC, New Delhi, Lala Ram Sarup Institute of TB & Respiratory diseases, New Delhi, RRL, Jammu; CSIR, New Delhi, Advanced Transfusion Medicine Research Foundation, Ahmedabad; National Institute of Immunology, New Delhi; Trieste, Italy etc.
Cadila Pharmaceuticals Products and Services:
Cadila is the only manufacturer of natural Streptokinase and Hyaluronic Acid products in India. They are the first to introduce Rabeprazole in IV form – ‘Rabeloc’ in the world.
The pharmaceutical company introduced the world’s first boosted-Rifampicin fixed-dose combination for the treatment of Tuberculosis – ‘Risorine’ and world’s first drug combination for prevention of Cardiovascular Diseases – ‘Polycap’ in 2009.
They have recently introduces ‘Mycidac-C’ – first in the class active immunotherapy as well as drug targeting Desmocollin for the patients suffering from Non-Small Cell Lung Cancer (NSCLC).
Here are some of the top brands of the company Rabiloc, Trigan-D, Mycobutol and Sepsivac, Haem Up, Vasograin, Tricort, Fludac, Aciloc, Envas, Calcirol etc.
Cadila pharmaceuticals subsidiaries:
- Apollo Hospitals International Ltd.
- Cadila Pharmaceuticals Sweden AB
- Satellite Overseas (Holdings) Limited
- CPL Inc
- Kadera Yakuhin Ltd
Specialties: Bulg Drugs/API, Finished Formulations, Discovery Research Services, Pre-Clinical/Clinical Trials, Contract Manufacturing, Agro products, Pharma Machinery, generic drugs.
Alliances:
Cadila Pharmaceuticals formed a partnership with a Norwegian start-up from in 2019.
They named it Serca Pharmaceuticals. It develops new treatment for heart patients.
Awards and Recognition:
Following are the list of awards and recognitions achieved by Cadila.
- WorldStar Packaging Award in 2018
- TISS LeapVault CLO Award in 2019
- Observenow Future of Workplace Award in 2019
- Great Place to Work Certified in 2020
Here you can find the company information of Cadila Pharmaceuticals Limited such as a business address, Manufacturing Plants, and contact Numbers of the company, etc.. At Suger Mint, the company listed in the pharmaceutical company category..
Corporate Offices & Manufacturing Plants:
Ahmedabad:
Sarkhej-Dholka Road, Bhat, Ahmedabad, India, 382210
Contact Numbers: +91 2718 225039, +91 2718 225001
Dholka Manufacturing Plant:
Survey No. 1389, Trasad Road, Dholka, Ahmedabad, India, 382225
Contact Numbers: +91 2714 220315, 2714 221481
Ankleshwar API SBU:
294, GIDC Estate, Ankleshwar, India, 393002
Contact Numbers: +91 2646 250051, 2646 223846
Jammu Manufacturing Plant
Are you an
Entrepreneur or Startup? Do you have a Success Story to Share? SugerMint would like to share your success story. We cover entrepreneur Stories, Startup News, Women entrepreneur stories, and Startup stories
|
IGC, Phase-1, SIDCO, Samba, Jammu, J&K, 184121
Contact Numbers: +91 01923 246981